Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2025-12-25 @ 1:40 AM
NCT ID:
NCT03766594
Eligibility Criteria:
Inclusion Criteria:
* Age: 20-35 years.
* BMI (20-30)
* History of three or more successive unexplained recurrent miscarriage.
* Normal uterine cavity by hystrography or hysteroscopy.
* No luteal phase defects by progesterone \> 10 ng.
* Normal thyroid function (TSH, T3, T4)
* Normal lupus anticoagulant measured by activated partial throbmoplastine time (32-43 seconds).
* Normal anticardolipin (IgG \< 20 gpl and IgM \< 15 MPL measured by ELISA).
* Normal anti thyroid antibodies.
* Normal glucouse tolerance test.
* Normal parental karyotyping.
Exclusion Criteria:
* Age\<20 or\>35 year
* BMI\<20 or\>30
* Systemic diseases that might affect pregnancy such as diabetes or thyroid disorders or hypertension.
* History of consanguinity.
* Family history of chromosomal abnormalities (e.g. trisomy 21, trisomy 13, Turner's disease …etc.).
* History of autoimmune diseases, eg: systemic lupus.
* Congenital anomaly in uterine cavity as bicornate or septate uterus.
* Luteal phase defect and corpus luteum insufficiency.
* Uterine masses as fibroid or polyps.
* Patient with patuoles os.
* patient with antiphosphlipid syndrome.
* Cigarette smoking and alcohol.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
20 Years
Maximum Age:
35 Years
Study:
NCT03766594
Study Brief:
Protocol Section:
NCT03766594